NCT00426127View on ClinicalTrials.gov

Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

August 31, 2009

Conditions

Pancreatic Cancer

Interventions

DRUG

Docetaxel

DRUG

Liposomal Doxorubicin

DRUG

Enoxaparin

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

Sponsors

Collaborators (1)

Aventis Pharmaceuticals

All Listed Sponsors

collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

University of Iowa

OTHER